ZA200200692B - An improved amorphous form of cefpodoxime proxetil. - Google Patents

An improved amorphous form of cefpodoxime proxetil. Download PDF

Info

Publication number
ZA200200692B
ZA200200692B ZA200200692A ZA200200692A ZA200200692B ZA 200200692 B ZA200200692 B ZA 200200692B ZA 200200692 A ZA200200692 A ZA 200200692A ZA 200200692 A ZA200200692 A ZA 200200692A ZA 200200692 B ZA200200692 B ZA 200200692B
Authority
ZA
South Africa
Prior art keywords
cefpodoxime proxetil
amorphous form
solvent
prepared
mixtures
Prior art date
Application number
ZA200200692A
Other languages
English (en)
Inventor
Yatendra Kumar
Arora Rakesh Kumar
Kaptan Singh
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of ZA200200692B publication Critical patent/ZA200200692B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200200692A 1999-07-30 2002-01-25 An improved amorphous form of cefpodoxime proxetil. ZA200200692B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1036DE1999 IN191496B (OSRAM) 1999-07-30 1999-07-30

Publications (1)

Publication Number Publication Date
ZA200200692B true ZA200200692B (en) 2003-05-28

Family

ID=11092065

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200692A ZA200200692B (en) 1999-07-30 2002-01-25 An improved amorphous form of cefpodoxime proxetil.

Country Status (9)

Country Link
US (1) US6602999B1 (OSRAM)
EP (1) EP1204667A4 (OSRAM)
JP (1) JP2003506329A (OSRAM)
CN (1) CN1371381A (OSRAM)
AU (1) AU5839100A (OSRAM)
BR (1) BR0012865A (OSRAM)
IN (1) IN191496B (OSRAM)
WO (1) WO2001009143A1 (OSRAM)
ZA (1) ZA200200692B (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT408226B (de) * 1999-05-05 2001-09-25 Biochemie Gmbh Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2
EP1373276A4 (en) 2001-02-27 2005-03-02 Ranbaxy Lab Ltd PROCESS FOR THE PRODUCTION OF CEFPODOXIM PROXETIL
KR20070054730A (ko) * 2004-10-18 2007-05-29 테바 파마슈티컬 인더스트리즈 리미티드 알콜 및 케톤 및/또는 에스테르의 혼합물인 유기 용매에아토르바스타틴 헤미-칼슘 염을 용해시키고 용매를제거하여 비결정형 아토르바스타틴 헤미-칼슘을 제조하는방법
KR20080026109A (ko) * 2005-05-16 2008-03-24 엘란 파마 인터내셔널 리미티드 세팔로스포린을 함유하는 나노입자형 조절 방출 조성물
KR100840132B1 (ko) * 2007-04-17 2008-06-23 재단법인서울대학교산학협력재단 포화 액체 이산화탄소를 사용한 세포독심 프록세틸의 건조
US20150239848A1 (en) * 2012-09-11 2015-08-27 Dr. Reddy's Laboratories Limited Enzalutamide polymorphic forms and its preparation
MX363974B (es) * 2012-09-11 2019-04-10 Medivation Prostate Therapeutics Llc Formulaciones de enzalutamida.
MX2017011386A (es) 2015-03-06 2018-04-26 Atea Pharmaceuticals Inc NUCLEÓTIDOS DE PURINA ß-D-2'-DEOXI-2'A-FLUORO-2'-ß-C-SUSTITUIDOS-2 - MODIFICADOS-N6- SUSTITUIDOS PARA EL TRATAMIENTO DEL VIRUS DE LA HEPATITIS C.
WO2017046756A1 (en) * 2015-09-18 2017-03-23 Lupin Limited Proxetil and axetil esters of cefixime
US11447506B2 (en) 2016-05-09 2022-09-20 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
CN119751489A (zh) * 2016-05-09 2025-04-04 安纳考尔医药有限责任公司 克立硼罗游离形式的晶型及其制备方法和用途
WO2017218957A1 (en) * 2016-06-16 2017-12-21 Teva Pharmaceuticals International Gmbh Solid state forms of spiro-oxindole compounds
EP3510021A1 (en) * 2016-09-06 2019-07-17 Indena S.p.A. Solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) and method for preparing the same
CN109689672B (zh) 2016-09-07 2023-05-30 阿堤亚制药公司 用于rna病毒治疗的2’-取代的-n6-取代的嘌呤核苷酸
US10336679B2 (en) * 2016-10-24 2019-07-02 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
US11369579B2 (en) 2016-10-24 2022-06-28 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
IL295609B2 (en) * 2017-02-01 2023-11-01 Atea Pharmaceuticals Inc Nucleotide hemisulfate salt for the treatment of hepatitis C virus
EP3601265B1 (en) * 2017-03-30 2023-06-21 Merck Patent GmbH Solid form of (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)methanol
EP4285904A3 (en) * 2017-11-22 2023-12-20 Agios Pharmaceuticals, Inc. Crystalline forms of n-(4-(4-(cyclopropylmethyl) piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide
US11013741B1 (en) * 2018-04-05 2021-05-25 Sumitomo Dainippon Pharma Oncology, Inc. AXL kinase inhibitors and use of the same
WO2019200005A1 (en) 2018-04-10 2019-10-17 Atea Pharmaceuticals, Inc. Treatment of hcv infected patients with cirrhosis
CN110251467A (zh) * 2019-06-26 2019-09-20 北京济美堂医药研究有限公司 一种无定形态头孢妥仑匹酯组合物的制备方法
CN110437259B (zh) * 2019-08-14 2021-12-07 中国药科大学 头孢泊肟酯柚皮素共无定形物及其制备方法
JP2022551439A (ja) * 2019-10-04 2022-12-09 スミトモ ファーマ オンコロジー, インコーポレイテッド Axl阻害薬製剤
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19
WO2022176017A1 (ja) * 2021-02-16 2022-08-25 大塚製薬株式会社 非晶質体及び当該非晶質体を含む組成物
EP4530380A1 (en) 2022-05-23 2025-04-02 Nagoya Institute Of Technology Method for continuously producing biodegradable fiber material containing inorganic filler particles using wet spinning, and cotton-like bone regeneration material produced with said method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223153A (en) 1979-02-09 1980-09-16 Eli Lilly And Company Crystalline forms of N-2-(6-methoxy)benzothiazolyl N'-phenyl urea
IT1165253B (it) 1979-07-12 1987-04-22 Blasinachim Spa Procedimento di fabbricazione di acido chenodesossicolico cristallino puro
US4486425A (en) 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
IL100091A (en) 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
DK0531875T3 (da) * 1991-09-07 2004-06-21 Aventis Pharma Gmbh Diastereomer af 3-cephem-4-carboxylsyre-1-(-isopropoxycarbonyloxy)-ethylester og fremgangsmåde til dens fremstilling
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
AT413383B (de) * 1998-01-09 2006-02-15 Sandoz Ag Verfahren zur isolierung eines diastereoisomerengemisches von cefpodoxim proxetil
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물

Also Published As

Publication number Publication date
IN191496B (OSRAM) 2003-12-06
EP1204667A4 (en) 2002-10-30
JP2003506329A (ja) 2003-02-18
US6602999B1 (en) 2003-08-05
CN1371381A (zh) 2002-09-25
BR0012865A (pt) 2002-07-09
WO2001009143A1 (en) 2001-02-08
EP1204667A1 (en) 2002-05-15
AU5839100A (en) 2001-02-19

Similar Documents

Publication Publication Date Title
ZA200200692B (en) An improved amorphous form of cefpodoxime proxetil.
EP1619198B1 (en) Process for the preparation of amorphous cefuroxime axetil
US20220380304A1 (en) Novel method for producing peramivir trihydrate, and water-based drying thereof
AU2001270928A1 (en) Process for the preparation of highly pure crystalline (R,S) - cefuroxime axetil
WO2006024900A1 (en) Highly pure cefditoren pivoxil
CN103874692A (zh) 卡巴他赛的无定形形式和用于其制备的方法
WO2005044824A2 (en) Processes for the preparation of highly pure 3-(2-substituted vinyl) cephalosporin
MXPA03003483A (es) Procedimiento para la preparacion de acilfenilalaninas.
WO2000071124A1 (en) Amorphous form of fexofenadine hydrochloride
WO2018029699A1 (en) Solid state forms of (2e)-n-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide and process for preparation thereof
US6458558B1 (en) Process for the preparation of β-lactam derivatives
US20240300930A1 (en) Novel process for the preparation of 2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide
CN113372368B (zh) 一种弹性蛋白酶抑制剂前药及其用途
WO2021117062A1 (en) Process for the preparation of 4-[7-(6-Cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7- diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide and its polymorphs
WO2001079208A1 (fr) Nouveau derive d'azetidine et procede de preparation de celui-ci
US6858414B2 (en) Multistage process for the preparation of highly pure deferoxamine mesylate salt
CN112458141A (zh) 一种3-羟甲基头孢噻肟的制备方法
WO2008092306A1 (fr) Procédé d'hémisynthèse de taxol et de docétaxel
CN108640912A (zh) 一种匹多莫德的工业化规模制备方法
Rajan et al. A PROCESS FOR THE PREPARATION OF SAMIDORPHAN AND ITS INTERMEDIATES
WO2025104754A1 (en) A process for the preparation of samidorphan and its intermediates
JP2002205994A (ja) セフジトレンピボキシル有機酸塩、無機酸塩、及びその製造方法
WO2004056834A1 (en) A process for the preparation of cefpodoxime proxetil
CN120590409A (zh) 头孢地尔中间体i的合成方法
CN118930482A (zh) 一种西他沙星杂质p-2的制备方法